<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 07 Apr 2021 19:20:05 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>TIGIT+记忆B细胞在免疫调节中的作用</title><link>https://mp.weixin.qq.com/s/ojkM_fL6WYq2Hfqa5KwFDw</link><description></description><content:encoded><![CDATA[TIGIT+记忆B细胞在免疫调节中的作用]]></content:encoded><pubDate>Wed, 07 Apr 2021 19:03:47 +0800</pubDate></item><item><title>抗体药物动态-20210407</title><link>https://mp.weixin.qq.com/s/Ca7bpEJCk1w0IDPsp7Q4CQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210407]]></content:encoded><pubDate>Wed, 07 Apr 2021 19:03:47 +0800</pubDate></item><item><title>TG-Bio第二届免疫治疗技术大会开幕在即，聚焦细胞/基因治疗！</title><link>https://mp.weixin.qq.com/s/PHdd3N-0SilqN6AM1jF9mg</link><description></description><content:encoded><![CDATA[TG-Bio第二届免疫治疗技术大会开幕在即，聚焦细胞/基因治疗！]]></content:encoded><pubDate>Wed, 07 Apr 2021 19:03:47 +0800</pubDate></item><item><title>全球第五款上市的CAR-T药物：靶向BCMA</title><link>https://mp.weixin.qq.com/s/kLDNZ694Y60EChTgGk6Uig</link><description></description><content:encoded><![CDATA[全球第五款上市的CAR-T药物：靶向BCMA]]></content:encoded><pubDate>Tue, 06 Apr 2021 18:57:05 +0800</pubDate></item><item><title>抗体药物动态-20210406</title><link>https://mp.weixin.qq.com/s/rZCt662Xa3a6Gj3fk28GWg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210406]]></content:encoded><pubDate>Tue, 06 Apr 2021 18:57:05 +0800</pubDate></item><item><title>ADCC效应强于IgG，IgA成药难点和工程改造!</title><link>https://mp.weixin.qq.com/s/loS6bFoYEKFZwlifeVVVfQ</link><description></description><content:encoded><![CDATA[ADCC效应强于IgG，IgA成药难点和工程改造!]]></content:encoded><pubDate>Tue, 30 Mar 2021 18:46:05 +0800</pubDate></item><item><title>抗体药物动态-20210330</title><link>https://mp.weixin.qq.com/s/iIzTJBECqpdwmNty_PHUOQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210330]]></content:encoded><pubDate>Tue, 30 Mar 2021 18:46:05 +0800</pubDate></item><item><title>帮助Moderna开发mRNA疫苗的背后，Ginkgo正在探索加帽酶的规模生产</title><link>https://mp.weixin.qq.com/s/L4YeysqIBkiU1xeCVSSh5g</link><description></description><content:encoded><![CDATA[帮助Moderna开发mRNA疫苗的背后，Ginkgo正在探索加帽酶的规模生产]]></content:encoded><pubDate>Mon, 29 Mar 2021 18:23:51 +0800</pubDate></item><item><title>抗体药物动态-20210329</title><link>https://mp.weixin.qq.com/s/QgkuFIGpjKSpScNcE5hQng</link><description></description><content:encoded><![CDATA[抗体药物动态-20210329]]></content:encoded><pubDate>Mon, 29 Mar 2021 18:23:51 +0800</pubDate></item><item><title>肿瘤治疗新秀：mRNA疫苗</title><link>https://mp.weixin.qq.com/s/3lyfNWIpRLrmoWcLc5SaqA</link><description></description><content:encoded><![CDATA[肿瘤治疗新秀：mRNA疫苗]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:53:43 +0800</pubDate></item><item><title>抗体药物动态-20210326</title><link>https://mp.weixin.qq.com/s/ckcZ5SDsyX8NJVK40WczuA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210326]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:53:43 +0800</pubDate></item><item><title>免疫损伤后的T细胞再生</title><link>https://mp.weixin.qq.com/s/b3jHx6P7lAvYqmhlQn0GpA</link><description></description><content:encoded><![CDATA[免疫损伤后的T细胞再生]]></content:encoded><pubDate>Thu, 25 Mar 2021 18:57:34 +0800</pubDate></item><item><title>【盘点】ADC药物的江湖</title><link>https://mp.weixin.qq.com/s/u845xbyvqYiNAQsv0h6eqg</link><description></description><content:encoded><![CDATA[【盘点】ADC药物的江湖]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:26:09 +0800</pubDate></item><item><title>抗体药物动态-20210324</title><link>https://mp.weixin.qq.com/s/SvGsbvXCjcLQedAWg2wIyA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210324]]></content:encoded><pubDate>Wed, 24 Mar 2021 18:26:09 +0800</pubDate></item><item><title>VEGF-VEFGR通路</title><link>https://mp.weixin.qq.com/s/TXo8t3sKqZlXUZ2ollWX7w</link><description></description><content:encoded><![CDATA[VEGF-VEFGR通路]]></content:encoded><pubDate>Tue, 23 Mar 2021 18:16:21 +0800</pubDate></item><item><title>Science重磅：CAR-T攻克实体瘤的质的飞跃，只杀癌细胞，不伤健康细胞</title><link>https://mp.weixin.qq.com/s/47X_6Ci7WQiGVrvUfQHWow</link><description></description><content:encoded><![CDATA[Science重磅：CAR-T攻克实体瘤的质的飞跃，只杀癌细胞，不伤健康细胞]]></content:encoded><pubDate>Mon, 22 Mar 2021 19:07:04 +0800</pubDate></item><item><title>抗体药物动态-20210322</title><link>https://mp.weixin.qq.com/s/fabIs5ueuF7HKpQRP5N5FQ</link><description></description><content:encoded><![CDATA[抗体药物动态-20210322]]></content:encoded><pubDate>Mon, 22 Mar 2021 19:07:04 +0800</pubDate></item><item><title>CAR T细胞生产中的问题和挑战</title><link>https://mp.weixin.qq.com/s/zftUvnvnwjvn7lWfAZiTFQ</link><description></description><content:encoded><![CDATA[CAR T细胞生产中的问题和挑战]]></content:encoded><pubDate>Wed, 17 Mar 2021 19:17:02 +0800</pubDate></item><item><title>抗体药物动态-20210317</title><link>https://mp.weixin.qq.com/s/02Ko6rph92wMT1fj5hmJ9Q</link><description></description><content:encoded><![CDATA[抗体药物动态-20210317]]></content:encoded><pubDate>Wed, 17 Mar 2021 19:17:02 +0800</pubDate></item></channel></rss>